Condition: Neurocognitive Disorders, Mild · Cognitive Impairment, Mild · Depression Mild · Sponsor: KompanionCare SAS
This study aims to observe the effects of daily personalized digital reminiscence sessions, conducted with the help of a digital conversational agent, and to determine whether these sessions lead to improvements in symptoms such as apathy and depression. The researchers therefore seek to observe whether this daily use can improve certain aspects of well-being, such as motivation, mood, sleep quality, quality of life, and engagement with the tool. The study also aims to assess whether simple reminders delivered via the application are sufficient to encourage regular use without external assistance. Participants will: * Use the reminiscence app for 25 days for 10-15 minutes. * Have a primary caregiver help personalize the app by sharing family memories, other relatives may optionally contribute in a private group. * Complete brief questionnaires at the start and during follow-up routine visits (for example, apathy and depression scales, sleep, and quality of life).
This description comes directly from the study's public registry record.
Peter MARKUS · +36303621811 · peter@kompanioncare.com
Always discuss trial participation with your own doctor first.
| CHU Angers, Service médecine gériatrique. | Angers, France | Recruiting |
| Limoges University Hospital Center - Dupuytren Hospital], Geriatric medicine department | Limoges, France | Recruiting |
| Centre Hospitalier Universitaire de Nice - Institut Claude Pompidou, Centre Mémoire de Ressources et de Recherches (CM2R) | Nice, France | Recruiting |
| APHP Hôpitaux universitaires Paris centre. | Paris, France | Not Yet Recruiting |
| CHU DE TOURS, Pôle Vieillissement, Hôpital Bretonneau. | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07237009